Ozempic Maker Novo Nordisk Lowers Growth Outlook of Its Blockbuster Drugs
Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy hold back sales at the pharma giant.
Source link
Get latast news super fast
